PS Ratio Chart

View PS Ratio for MCRXF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View PS Ratio Chart
Start Trial

Historical PS Ratio Data

View and export this data back to 2021. Start Trial.
Date Value
August 25, 2026 2.692
August 24, 2026 1.992
August 21, 2026 1.992
August 20, 2026 1.992
August 19, 2026 1.992
August 18, 2026 1.992
August 17, 2026 1.992
August 14, 2026 1.992
August 13, 2026 1.615
August 12, 2026 1.615
August 11, 2026 1.615
August 10, 2026 1.615
August 07, 2026 1.615
August 06, 2026 1.615
August 05, 2026 1.615
August 04, 2026 1.615
August 03, 2026 1.615
July 31, 2026 1.615
July 30, 2026 1.615
July 29, 2026 1.615
July 28, 2026 1.615
July 27, 2026 0.8076
July 24, 2026 0.8076
July 23, 2026 0.8076
July 22, 2026 1.615
Date Value
July 21, 2026 1.615
July 20, 2026 1.615
July 17, 2026 1.615
July 16, 2026 1.615
July 15, 2026 1.615
July 14, 2026 1.508
July 13, 2026 1.508
July 10, 2026 1.508
July 09, 2026 1.508
July 08, 2026 1.508
July 07, 2026 1.508
July 06, 2026 1.508
July 02, 2026 1.508
July 01, 2026 1.508
June 30, 2026 1.508
June 29, 2026 1.508
June 26, 2026 1.615
June 25, 2026 1.615
June 24, 2026 1.615
June 23, 2026 1.615
June 22, 2026 1.615
June 18, 2026 1.615
June 17, 2026 1.615
June 16, 2026 1.669
June 15, 2026 1.669

Price to Sales Ratio Definition

The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.

Read full definition.

PS Ratio Range, Past 5 Years

View PS Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

PS Ratio Benchmarks

View PS Ratio Benchmarks
Start Trial
Cochlear Ltd. 4.086
ImpediMed Ltd. 0.8843
Nanosonics Ltd. 5.144
Somnomed Ltd. 1.268
Imagion Biosystems Ltd. --

PS Ratio Related Metrics

Price 0.05
Earnings Yield -23.00%
Market Cap 36.19M